Jim C. Hu

ORCID: 0000-0003-2562-8024
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Urologic and reproductive health conditions
  • Bladder and Urothelial Cancer Treatments
  • Economic and Financial Impacts of Cancer
  • Urinary Bladder and Prostate Research
  • Renal cell carcinoma treatment
  • Global Cancer Incidence and Screening
  • Health Systems, Economic Evaluations, Quality of Life
  • Urological Disorders and Treatments
  • Advanced Radiotherapy Techniques
  • Pelvic floor disorders treatments
  • Healthcare Policy and Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Colorectal Cancer Surgical Treatments
  • Genital Health and Disease
  • Radiomics and Machine Learning in Medical Imaging
  • Colorectal Cancer Screening and Detection
  • Renal and Vascular Pathologies
  • Hormonal and reproductive studies
  • Surgical Simulation and Training
  • Multiple and Secondary Primary Cancers
  • Male Reproductive Health Studies
  • Sexual function and dysfunction studies
  • Endometrial and Cervical Cancer Treatments

Cornell University
2016-2025

Presbyterian Hospital
2016-2025

New York Hospital Queens
2015-2024

Weill Cornell Medicine
2016-2024

NewYork–Presbyterian Hospital
2015-2024

Peking University
2024

Shanghai Medical College of Fudan University
2024

Zhongshan Hospital
2024

Széchenyi István University
2023

Jiaxing University
2023

Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men a raised prostate-specific antigen level who have not undergone biopsy. However, comparative evidence limited.In multicenter, randomized, noninferiority trial, we assigned clinical suspicion of prostate cancer had previously undergo MRI, Men the MRI-targeted group underwent (without cores) if MRI was...

10.1056/nejmoa1801993 article EN New England Journal of Medicine 2018-03-19

To examine the impact of marital status on stage at diagnosis, use definitive therapy, and cancer-specific mortality among each 10 leading causes cancer-related death in United States.We used Surveillance, Epidemiology End Results program to identify 1,260,898 patients diagnosed 2004 through 2008 with lung, colorectal, breast, pancreatic, prostate, liver/intrahepatic bile duct, non-Hodgkin lymphoma, head/neck, ovarian, or esophageal cancer. We multivariable logistic Cox regression analyze...

10.1200/jco.2013.49.6489 article EN Journal of Clinical Oncology 2013-09-24

Minimally invasive radical prostatectomy (MIRP) has diffused rapidly despite limited data on outcomes and greater costs compared with open retropubic (RRP).To determine the comparative effectiveness of MIRP vs RRP.Population-based observational cohort study using US Surveillance, Epidemiology, End Results Medicare linked from 2003 through 2007. We identified men prostate cancer who underwent (n = 1938) RRP 6899).We postoperative 30-day complications, anastomotic stricture 31 to 365 days...

10.1001/jama.2009.1451 article EN JAMA 2009-10-13

New York City was the international epicenter of COVID-19 pandemic. Health care providers responded by rapidly transitioning from in-person to video consultations. Telemedicine (ie, visits) is a potentially disruptive innovation; however, little known about patient satisfaction with this emerging alternative traditional clinical encounter.This study aimed determine if differs between and visits.In retrospective observational cohort study, we analyzed 38,609 Press Ganey survey outcomes clinic...

10.2196/20786 article EN cc-by Journal of Medical Internet Research 2020-08-06

Intensity-modulated radiation therapy (IMRT) and laparoscopic or robotic minimally invasive radical prostatectomy (MIRP) are costlier alternatives to three-dimensional conformal (3D-CRT) open for treating prostate cancer. We assessed temporal trends in their utilization impact on national health care spending.Using Surveillance, Epidemiology, End Results-Medicare linked data, we determined treatment patterns 45,636 men age ≥ 65 years who received definitive surgery localized cancer diagnosed...

10.1200/jco.2010.31.1217 article EN Journal of Clinical Oncology 2011-03-15

No AccessJournal of UrologyAdult Urology1 Apr 2012Use, Costs and Comparative Effectiveness Robotic Assisted, Laparoscopic Open Urological Surgery Hua-yin Yu, Nathanael D. Hevelone, Stuart R. Lipsitz, Keith J. Kowalczyk, Jim C. Hu YuHua-yin Yu Division Urology, Brigham Women's/Faulkner Hospital, Harvard Medical School, Boston, Massachusetts , HeveloneNathanael Hevelone Center for Public Health, LipsitzStuart Lipsitz KowalczykKeith Kowalczyk HuJim View All Author...

10.1016/j.juro.2011.11.089 article EN The Journal of Urology 2012-02-16

BACKGROUND To the authors' knowledge, it remains unknown whether race‐based differences in cancer outcomes have changed with time. In current study, authors assessed racial disparities cancer‐specific mortality improved over last 20 years. METHODS The Surveillance, Epidemiology, and End Results program was used to identify 2,713,474 patients diagnosed between 1988 2007 either lung, breast, prostate, or colorectal (the leading 3 causes of cancer‐related among each sex). After exclusions,...

10.1002/cncr.28617 article EN Cancer 2014-02-22

Given the lack of randomized trials comparing robot-assisted radical prostatectomy (RARP) and open (ORP), we sought to re-examine outcomes these techniques using a cohort patients treated in postdissemination era.Overall, data from 5,915 with prostate cancer RARP or ORP within SEER-Medicare linked database diagnosed between October 2008 December 2009 were abstracted. Postoperative complications, blood transfusions, prolonged length stay (pLOS), readmission, additional therapies, costs care...

10.1200/jco.2013.53.5096 article EN Journal of Clinical Oncology 2014-04-15

To examine the effect of hospital and surgeon volume on postoperative outcomes to determine whether or is stronger predictor.Using 1997 1998 claims data from a national 5% random sample Medicare beneficiaries, we identified 2,292 men who underwent radical prostatectomy at 1,210 hospitals by 1,788 surgeons. Hospitals were classified as high (> = 60 per year) low (< according experience over 2-year period. Surgeons 40 volume. Multivariate logistic regression was performed control for patient...

10.1200/jco.2003.05.169 article EN Journal of Clinical Oncology 2003-01-30

While it remains controversial whether LRP or da Vinci RAP offers any advantages over radical retropubic prostatectomy, and are being used more frequently. We reviewed our experience with these minimally invasive techniques.We intraoperative early postoperative complications of 358 LRPs performed from October 2000 to January 2003 those 322 RAPs June 2004. The transperitoneal approach bilateral pelvic lymph node dissection was using each technique. Data acquisition done independently the 3...

10.1016/s0022-5347(05)00156-4 article EN The Journal of Urology 2006-01-08

Demand for minimally invasive radical prostatectomy (MIRP) to treat prostate cancer is increasing; however, outcomes remain unclear. We assessed utilization, complications, lengths of stay, and salvage therapy rates MIRP versus open whether surgeon volume associated with better outcomes.We identified 2,702 men undergoing during 2003 2005 from a national 5% sample Medicare beneficiaries. the association between surgical approach outcomes, adjusting volume, age, race, comorbidity, geographic...

10.1200/jco.2007.13.4528 article EN Journal of Clinical Oncology 2008-05-08

No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Feb 2004Predicting Quality Life After Radical Prostatectomy: Results From CaPSURE JIM C. HU, ERIC P. ELKIN, DAVID J. PASTA, DEBORAH LUBECK, MICHAEL W. KATTAN, PETER R. CARROLL, and MARK S. LITWIN HUJIM HU , ELKINERIC ELKIN PASTADAVID PASTA LUBECKDEBORAH LUBECK KATTANMICHAEL KATTAN CARROLLPETER CARROLL LITWINMARK View All Author Informationhttps://doi.org/10.1097/01.ju.0000107964.61300.f6AboutFull TextPDF ToolsAdd to...

10.1097/01.ju.0000107964.61300.f6 article EN The Journal of Urology 2004-02-01

Given the costs of delivering care for men with prostate cancer remain poorly described, this article reports results time-driven activity-based costing (TDABC) competing treatments low-risk cancer. Process maps were developed each phase from initial urologic visit through 12 years follow-up robotic-assisted laparoscopic prostatectomy (RALP), cryotherapy, high-dose rate (HDR) and low-dose (LDR) brachytherapy, intensity-modulated radiation therapy (IMRT), stereotactic body (SBRT), active...

10.1002/cncr.29743 article EN Cancer 2015-11-02

Purpose Androgen deprivation therapy (ADT) may contribute to depression, yet several studies have not demonstrated a link. We aimed determine whether receipt of any ADT or longer duration for prostate cancer (PCa) is associated with an increased risk depression. Methods identified 78,552 men older than age 65 years stage I III PCa using the SEER-Medicare–linked database from 1992 2006, excluding patients psychiatric diagnoses within prior year. Our primary analysis was association between...

10.1200/jco.2015.64.1969 article EN Journal of Clinical Oncology 2016-04-12

Purpose Although demographic, clinicopathologic, and socioeconomic differences may affect treatment outcomes of prostate cancer, the effect mental health disorders remains unclear. We assessed previously diagnosed depression on men with newly cancer. Patients Methods performed a population-based observational cohort study using Surveillance, Epidemiology, End Results-Medicare linked data 41,275 clinically localized cancer from 2004 to 2007. identified 1,894 depressive disorder in 2 years...

10.1200/jco.2013.51.1048 article EN Journal of Clinical Oncology 2014-07-08

This population-based study assesses the effect of decline in prostate-specific antigen screening and incidence on prostate cancer presentation.

10.1001/jamaoncol.2016.5465 article EN JAMA Oncology 2016-12-29

No AccessJournal of UrologyAdult Urology1 Aug 2014Targeted Prostate Biopsy to Select Men for Active Surveillance: Do the Epstein Criteria Still Apply? Jim C. Hu, Edward Chang, Shyam Natarajan, Daniel J. Margolis, Malu Macairan, Patricia Lieu, Jiaoti Huang, Geoffrey Sonn, Frederick Dorey, and Leonard S. Marks HuJim Hu , ChangEdward Chang NatarajanShyam Natarajan MargolisDaniel Margolis MacairanMalu Macairan LieuPatricia Lieu HuangJiaoti Huang SonnGeoffrey Sonn DoreyFrederick Dorey...

10.1016/j.juro.2014.02.005 article EN The Journal of Urology 2014-02-08
Coming Soon ...